PRKAG2 and familial hypertrophic cardiomyopathy: The mutations in PRKAG2 were first related to familial hypertrophic cardiomyopathy (HCM) [22], yet Arad et al. revealed that the PRKAG2 mutations affect metabolic cardiomyopathy rather than HCM [23].